11/18/2024
6:00 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
3:59 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:29 PM | Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2024
3:17 PM | Dulac Edward J III (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:13 PM | Dulac Edward J III (Reporting)
Intellia Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
|
07/18/2024
3:03 PM | Intellia Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/03/2024
12:15 PM | Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
12:15 PM | Clark Eliana (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
7:06 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
4:00 PM | Intellia Therapeutics (Issuer)
Verwiel Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:14 PM | Goff Brian (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:15 PM | Goff Brian (Reporting)
Intellia Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/14/2024
3:16 PM | CHASE WILLIAM J (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:18 PM | Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:19 PM | Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:20 PM | GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:21 PM | Intellia Therapeutics (Issuer)
Keresty Georgia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:22 PM | Intellia Therapeutics (Issuer)
Verwiel Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:25 PM | Intellia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:40 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:16 PM | Intellia Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:10 PM | Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/15/2024
3:21 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
8:26 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
6:04 AM | Intellia Therapeutics (Filer)
| Form 424B5 | |
02/23/2024
4:22 PM | Intellia Therapeutics (Filer)
| Form 424B5 | |
02/23/2024
4:17 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
3:00 PM | ARK Investment Management LLC (Filed by)
Intellia Therapeutics (Subject)
| Form SC 13G/A | |
01/24/2024
10:21 AM | Intellia Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/10/2024
3:15 PM | Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:35 PM | BlackRock Inc. (Filed by)
Intellia Therapeutics (Subject)
| Form SC 13G/A | |
01/05/2024
3:44 PM | Clark Eliana (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:45 PM | BASTA JAMES (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:46 PM | Hicks Derek (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:49 PM | Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:50 PM | Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:50 PM | Intellia Therapeutics (Issuer)
Lebwohl David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:51 PM | Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
We recommended Palantir in 2021, now we’re recommending this... (Ad) My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol |
01/04/2024
3:07 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
4:28 PM | Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:30 PM | Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:34 PM | Intellia Therapeutics (Issuer)
Lebwohl David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:35 PM | Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free NTLA Stock Alerts